Solution:

Streptokinase, produced by the bacterium Streptococcus, is utilized as a ‘clot buster.’ This enzyme has a fibrinolytic activity, which means it breaks down clots that form in the blood arteries of myocardial infarction patients. This prevents cardiac attacks in these patients, which could otherwise occur due to clot blockage.